Max Goes to the World Cancer Congress
The Union for International Cancer Control (UICC) has been hosting the World Cancer Congress each year since 1933. This year it was held in Malaysia – the first time in South East Asia.
Get a never before seen look at the chronic myeloid leukemia (CML) program in Tanzania! Over 20 years ago, we partnered with local healthcare professionals to provide treatment access for people living with cancer – at no cost to them, for as long as they need
it.
Africa Region Head Cathy Scheepers takes you to clinics in Moshi and Dar es Salaam, talking with patients, advocates, and physicians about their progress and how we can reach more people living with CML.
Stay tuned for more behind-the-scenes videos! Cathy and the Max team will be visiting several countries this year, including Lesotho, Kenya, Malawi, Sierra Leone, and Ethiopia.
Join our email list for updates and follow along on social media to join the conversation.

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Take the Chai Five challenge to raise awareness of the needs of cancer survivors while raising funds for their support! What is “Chai Five”? The Chai Five is a list of five simple actions you can take to support people in India who are facing a cancer diagnosis.

Last week ASCO launched the inaugural issue of the Journal of Global Oncology. This new open access, online journal focuses exclusively on cancer research, treatment, and the delivery of care in middle and low resource countries.
Among the first seven articles, published on September 23rd, are original research, commentaries, and review articles, including a special article looking at the Glivec International Patient Assistance Program (GIPAP), authored by our CEO Pat Garcia-Gonzalez, MS, and others.